Triozzi
Pierre Triozzi, Shaker Heights, OH US
Patent application number | Description | Published |
---|---|---|
20090075941 | TREATING NEOPLASMS - Methods of treating a subject with neoplasm (e.g., mesothelioma) or at risk of developing neoplasm by administering a mevalonate pathway inhibitor such as a nitrogen-containing bisphosphonate are disclosed. Examples of nitrogen-containing bisphosphonates include alendronate, ibandronate, minodronate, neridronate, olpadronate, pamidronate, risedronate, and zoledronate. The methods can further include the administration of a p38 inhibitor. Further disclosed are compositions and kits including a nitrogen-containing bisphosphonate and optionally a p38 inhibitor. | 03-19-2009 |
Pierre Triozzi, Washington, DC US
Patent application number | Description | Published |
---|---|---|
20120141371 | ANTIBODY COMPOSITIONS, METHODS FOR TREATING NEOPLASTIC DISEASE AND METHODS FOR REGULATING FERTILITY - Antibody compositions and methods for inhibition of the effects of gonadotropin hormones are provided. Methods for treating cancer and methods for regulating fertility are provided by administration of the antibody compositions to a mammalian subject in need thereof. | 06-07-2012 |
Pierre L. Triozzi, Shaker Hts., OH US
Patent application number | Description | Published |
---|---|---|
20150159225 | UVEAL MELANOMA PROGNOSIS - Methods and kits for monitoring or providing a prognosis for a subject having uveal melanoma are described. The methods include obtaining a biological sample from the subject, determining the expression level of one or more uveal melanoma-associated miRs and/or miR biogenesis factors in the biological sample, and characterizing the subject as high risk if one or more uveal melanoma-associated miRs and/or miR biogenesis factors are differentially expressed as compared with a corresponding control. | 06-11-2015 |